Literature DB >> 72951

Suppression of gonadotrophin release in many by an inhibitory analogue of L.H.-releasing hormone.

D Gonzalez-Barcena, A J Kastin, D H Coy, K Nikolics, A V Schally.   

Abstract

The ability of an inhibitory analogue of L.H.-releasing hormone (L.H.R.H.) to suppress the release of luteinising hormone (L.H.) and follicle-stimulating hormone (F.S.H.) after administration of a small does of L.H.R.H. was tested in four men. A single intramuscular injection of 90 mg (D-Phe-2,D-Trp-3,D-Phe-6)-L.H.R.H. diminished the gonadotrophin response to 25 micrometer of L.H.R.H. given 1, 4, 8, and 24 hours afterwards. Basal levels of L.H. and F.S.H. were not lowered. The results demonstrate that an inhibitory analogue of L.H.R.H. is active in man and suggest the possibility that inhibitors of L.H.R.H. might eventually form the basis of a new method of birth control.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72951     DOI: 10.1016/s0140-6736(77)92893-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  1 in total

1.  Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone.

Authors:  T W Redding; D H Coy; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.